Why the study?
Does verapamil inhibit platelet aggregation and serotonin release in human platelets and healthy volunteers?
Population
Human platelets (in vitro) and healthy volunteers
Design
Preclinical
Follow-up
2 hours after drug ingestion
Authors
Loading...
May support mechanistic studies of verapamil in thrombosis; hypothesis-generating and should not yet change practice.
Does verapamil inhibit platelet aggregation and serotonin release in human platelets and healthy volunteers?
Verapamil demonstrates antiplatelet effects by inhibiting aggregation and serotonin release, suggesting a potential mechanistic role in managing thrombotic disorders.
Ikeda et al. (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: